|
Certain Guilford Pharmaceutical Officers To Sell Shares WASHINGTON -(Dow Jones)- Guilford Pharmaceuticals Inc. (GLFD) has been advised that certain officers and directors entered into individual asset diversification plans for the sale of shares of Guilford`s common stock, according to a Form 8-K filed Wednesday with the Securities and Exchange Commission. The sales plans are intended to qualify under Rule 10b5-1 of the Securities Exchange Act of 1934, which specifically contemplates and establishes certain legal benefits for persons who establish such plans. Each of the individualized plans is separate and distinct, and sales under the plans will not be coordinated or aggregated. Under the plans, specified amounts of shares will be sold, provided that specified trading prices are achieved. Each of the plans expires on a specific date in 2001 or 2002, upon the sale of all the shares covered by the plan or upon other specified events. Guilford Pharmaceuticals, Baltimore, is a biopharmaceutical company. -Brian Coyle; Dow Jones Newswires; 202-628-7695 (This story was originally published by Dow Jones Newswires) Copyright (c) 2001 Dow Jones & Company, Inc. All Rights Reserved Quelle: http://www.nasdaq.com |
|
| aus der Diskussion: | GUILFORD PHARMACEUTICALS - PART III |
| Autor (Datum des Eintrages): | Maiestro (28.07.01 00:56:39) |
| Beitrag: | 48 von 66 (ID:4073545) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |